These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 2868732

  • 1. General pharmacology of the anxiolytic compound metaclazepam in comparison to other benzodiazepines.
    Buschmann G, Kühl UG, Rohte O.
    Arzneimittelforschung; 1985; 35(11):1643-55. PubMed ID: 2868732
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T, Honbo T, Tokoro K, Kojimoto Y, Kodama R, Ohtsuka M, Shimomura K.
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [Abstract] [Full Text] [Related]

  • 6. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y, Makino M, Usui C, Takasuna K, Kasai Y, Hirohashi M, Tamura K, Takayama S, Kojima H, Iizuka H.
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.
    Yamasaki T, Kojima H, Tanaka M, Aibara S, Hirohashi M, Kasai Y, Tsubokawa M, Watanabe K, Akashi A.
    Arzneimittelforschung; 1981 Feb; 31(4):707-15. PubMed ID: 6113834
    [Abstract] [Full Text] [Related]

  • 8. [Pharmacological studies of a new sleep-inducer, 1H-1,2,4-triazolyl benzophenone derivative (450191-S) (V). General pharmacological activities].
    Yamamoto K, Ueda M, Kurosawa A, Hirose K, Doteuchi M, Nakamura M, Ozaki S, Matsumura S, Matsuda S, Satoh H.
    Nihon Yakurigaku Zasshi; 1984 Aug; 84(2):175-212. PubMed ID: 6149178
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.
    Yamashita S, Hosokawa T, Kojima M, Mori T, Yabuuchi Y.
    Arzneimittelforschung; 1984 Aug; 34(3A):342-6. PubMed ID: 6331464
    [Abstract] [Full Text] [Related]

  • 11. General pharmacology of the new quinolone antibacterial agent levofloxacin.
    Takasuna K, Kasai Y, Usui C, Takahashi M, Hirohashi M, Tamura K, Takayama S.
    Arzneimittelforschung; 1992 Mar; 43(3A):408-18. PubMed ID: 1622443
    [Abstract] [Full Text] [Related]

  • 12. The cardiovascular and autonomic properties of N-phenylpiperazine (NPP) in several animal models.
    Cohen MR, Hinsch E, Palkoski Z, Vergona R, Urbano S, Sztokalo J.
    J Pharmacol Exp Ther; 1982 Oct; 223(1):110-9. PubMed ID: 6126578
    [Abstract] [Full Text] [Related]

  • 13. [Action of benzodiazepines on spinal dorsal root reflex potentials in cats].
    Suzuki T.
    Nihon Yakurigaku Zasshi; 1984 Jul; 84(1):99-108. PubMed ID: 6149176
    [Abstract] [Full Text] [Related]

  • 14. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M, Koibuchi Y, Sakai S, Tsujioka K, Fujiwara T, Ozaki T, Maeda K, Motoyama I, Horiai H, Ono T.
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [Abstract] [Full Text] [Related]

  • 15. Positive inotropic and blood pressure lowering activity of a diterpene derivative isolated from Coleus forskohli: Forskolin.
    Lindner E, Dohadwalla AN, Bhattacharya BK.
    Arzneimittelforschung; 1978 Nov; 28(2):284-9. PubMed ID: 580393
    [Abstract] [Full Text] [Related]

  • 16. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M, Yajima M, Nishimura T, Ikeda H, Nishimori T.
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [Abstract] [Full Text] [Related]

  • 17. General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 1st communication: Effects on cardiovascular, visceral and renal functions and on blood.
    Matsuno Y, Taira N, Fujitani B, Ito T, Kadokawa T.
    Arzneimittelforschung; 1986 Jul; 36(1):55-62. PubMed ID: 3513777
    [Abstract] [Full Text] [Related]

  • 18. General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: Effect on the peripheral organs.
    Shintani S, Watanabe K, Kawamura K, Mori T, Tani T, Toba Y, Sasabe H, Nakagiri N, Hongoh O, Fujita S.
    Arzneimittelforschung; 1985 Jul; 35(7A):1163-72. PubMed ID: 3000392
    [Abstract] [Full Text] [Related]

  • 19. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
    Saito T, Ukai K, Masuda T, Nakagawa T, Kimura K, Fujii M, Wakatsuki K, Saeki M, Kasai H.
    Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
    [Abstract] [Full Text] [Related]

  • 20. [General pharmacology of 6-amino-2-fluoromethyl-3-(o-tolyl)-4(3H)-quinazolinone (afloqualone), a new centrally acting muscle relaxant. II. Effects on the peripheral system (author's transl)].
    Ochiai T, Fukuchi I, Ego H, Yamamura M, Kudo Y, Ishida R.
    Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):359-80. PubMed ID: 7327456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.